3.52
price up icon0.86%   0.03
pre-market  プレマーケット:  3.52  
loading
前日終値:
$3.49
開ける:
$3.51
24時間の取引高:
647.96K
Relative Volume:
0.60
時価総額:
$223.73M
収益:
$149.50M
当期純損益:
$-74.62M
株価収益率:
-2.9737
EPS:
-1.1837
ネットキャッシュフロー:
$-82.95M
1週間 パフォーマンス:
+2.03%
1か月 パフォーマンス:
+17.33%
6か月 パフォーマンス:
+108.28%
1年 パフォーマンス:
+179.37%
1日の値動き範囲:
Value
$3.495
$3.715
1週間の範囲:
Value
$3.30
$3.88
52週間の値動き範囲:
Value
$1.10
$3.88

Macrogenics Inc Stock (MGNX) Company Profile

Name
名前
Macrogenics Inc
Name
セクター
Healthcare (1112)
Name
電話
301-251-5172
Name
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
Name
職員
293
Name
Twitter
@macrogenics
Name
次回の収益日
2026-03-19
Name
最新のSEC提出書
Name
MGNX's Discussions on Twitter

Compare MGNX vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
MGNX icon
MGNX
Macrogenics Inc
3.52 221.82M 149.50M -74.62M -82.95M -1.1837
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
441.70 113.01B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
753.93 79.87B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
840.87 51.51B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
333.39 45.29B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
319.94 34.41B 5.36B 287.73M 924.18M 2.5229

Macrogenics Inc Stock (MGNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-10 アップグレード B. Riley Securities Neutral → Buy
2025-09-17 再開されました Barclays Overweight
2024-11-07 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2024-08-01 ダウングレード BTIG Research Buy → Neutral
2024-07-31 ダウングレード B. Riley Securities Buy → Neutral
2024-07-31 ダウングレード Guggenheim Buy → Neutral
2024-05-10 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-05-10 ダウングレード Stifel Buy → Hold
2024-05-10 ダウングレード TD Cowen Buy → Hold
2024-04-26 開始されました B. Riley Securities Buy
2024-04-09 アップグレード TD Cowen Hold → Buy
2024-03-04 繰り返されました BTIG Research Buy
2024-02-14 ダウングレード H.C. Wainwright Buy → Neutral
2023-12-20 アップグレード Citigroup Neutral → Buy
2023-11-07 アップグレード Guggenheim Neutral → Buy
2023-03-17 ダウングレード Guggenheim Buy → Neutral
2022-11-22 ダウングレード Cowen Outperform → Market Perform
2022-11-14 アップグレード BMO Capital Markets Market Perform → Outperform
2022-07-18 ダウングレード SMBC Nikko Outperform → Neutral
2022-07-11 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-05-04 ダウングレード Guggenheim Buy → Neutral
2022-02-28 アップグレード Citigroup Neutral → Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-02-04 開始されました SMBC Nikko Outperform
2021-11-17 再開されました Guggenheim Buy
2021-10-19 開始されました JMP Securities Mkt Outperform
2021-10-15 再開されました BTIG Research Buy
2021-04-26 再開されました Credit Suisse Outperform
2021-03-12 アップグレード Barclays Underweight → Overweight
2020-12-22 再開されました H.C. Wainwright Buy
2020-08-03 ダウングレード Citigroup Buy → Neutral
2020-06-01 アップグレード Guggenheim Neutral → Buy
2020-05-26 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Underweight
2019-12-19 開始されました Cantor Fitzgerald Overweight
2019-12-18 開始されました Cantor Fitzgerald Overweight
2019-11-21 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-11-20 再開されました Guggenheim Neutral
2019-05-03 アップグレード Wedbush Neutral → Outperform
2019-04-12 開始されました Guggenheim Neutral
2019-02-07 アップグレード Citigroup Sell → Buy
2019-02-07 ダウングレード Wedbush Outperform → Neutral
2019-02-06 アップグレード Raymond James Underperform → Mkt Perform
2019-02-04 ダウングレード Citigroup Neutral → Sell
2018-12-10 ダウングレード Raymond James Outperform → Underperform
2018-09-10 再開されました BTIG Research Buy
2018-05-31 開始されました Evercore ISI Outperform
2018-03-05 開始されました H.C. Wainwright Buy
2017-03-31 開始されました Raymond James Outperform
すべてを表示

Macrogenics Inc (MGNX) 最新ニュース

pulisher
Apr 13, 2026

Recap Report: What is the next catalyst for MacroGenics IncQuarterly Profit Report & AI Enhanced Trading Alerts - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 13, 2026

MacroGenics (MGNX) price target increased by 11.11% to 4.08 - MSN

Apr 13, 2026
pulisher
Apr 13, 2026

Sentiment Review: Whats the profit margin of MacroGenics Inc2026 Momentum Check & Real-Time Price Movement Reports - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 11, 2026

B Riley Securities upgrades MacroGenics (MGNX) - MSN

Apr 11, 2026
pulisher
Apr 11, 2026

MacroGenics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 11, 2026
pulisher
Apr 10, 2026

Today's Analyst Rating Data for MGNX: Major Upgrade by B. Riley Securities | MGNX Stock News - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

Today's Analyst Rating Data for MGNX: Major Upgrade by B. Riley - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

Macrogenics Inc Stock Historical Valuations | HAM:M55 - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

Macrogenics Inc Stock Intrinsic Values | HAM:M55 - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

MacroGenics: Oncology Opportunities In Play, But Investing Feels Like A Gamble (MGNX) - Seeking Alpha

Apr 10, 2026
pulisher
Apr 10, 2026

MacroGenics (NASDAQ:MGNX) Raised to "Buy" at B. Riley Financial - MarketBeat

Apr 10, 2026
pulisher
Apr 10, 2026

B.Riley upgrades MacroGenics stock rating on ADAM9 ADC potential By Investing.com - Investing.com South Africa

Apr 10, 2026
pulisher
Apr 10, 2026

B.Riley upgrades MacroGenics stock rating on ADAM9 ADC potential - Investing.com

Apr 10, 2026
pulisher
Apr 10, 2026

B. Riley Upgrades MacroGenics to Buy From Neutral, Triples Price Target to $9 From $3 - marketscreener.com

Apr 10, 2026
pulisher
Apr 10, 2026

JPMorgan Chase & Co. Increases Stake in MacroGenics, Inc. $MGNX - MarketBeat

Apr 10, 2026
pulisher
Apr 09, 2026

MacroGenics gains removal of FDA partial hold on lead program - MSN

Apr 09, 2026
pulisher
Apr 09, 2026

MacroGenics gains removal of FDA partial hold (MGNX:NASDAQ) - Seeking Alpha

Apr 09, 2026
pulisher
Apr 08, 2026

MacroGenics says FDA removes partial clinical hold on Phase 2 LINNET study - TipRanks

Apr 08, 2026
pulisher
Apr 08, 2026

FDA Lifts Partial Clinical Hold on MacroGenics’ LINNET Study for Lorigerlimab in Gynecologic Cancers, Enrollment to Resume - Minichart

Apr 08, 2026
pulisher
Apr 08, 2026

MacroGenics resumes enrollment in lorigerlimab cancer study By Investing.com - Investing.com Canada

Apr 08, 2026
pulisher
Apr 08, 2026

FDA Removes Partial Clinical Hold on MacroGenics' LINNET Study - Bitget

Apr 08, 2026
pulisher
Apr 08, 2026

MacroGenics resumes enrollment in lorigerlimab cancer study - Investing.com

Apr 08, 2026
pulisher
Apr 08, 2026

FDA Lifts Partial Hold on MacroGenics' (MGNX) LINNET Study - GuruFocus

Apr 08, 2026
pulisher
Apr 08, 2026

MacroGenics Resumes LINNET Trial After FDA Hold Lifted - TipRanks

Apr 08, 2026
pulisher
Apr 08, 2026

FDA Lifts Partial Clinical Hold on MacroGenics' LINNET Study; Enrollment to Resume - TradingView — Track All Markets

Apr 08, 2026
pulisher
Apr 08, 2026

FDA lifts hold on MacroGenics (NASDAQ: MGNX) LINNET gynecologic cancer trial - Stock Titan

Apr 08, 2026
pulisher
Apr 08, 2026

FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study - The Manila Times

Apr 08, 2026
pulisher
Apr 08, 2026

MacroGenics can enroll new cancer patients after FDA lifts study hold - Stock Titan

Apr 08, 2026
pulisher
Apr 08, 2026

[DEF 14A] MACROGENICS INC Definitive Proxy Statement - Stock Titan

Apr 08, 2026
pulisher
Apr 08, 2026

MacroGenics (NASDAQ:MGNX) Stock Crosses Above Fifty Day Moving AverageWhat's Next? - MarketBeat

Apr 08, 2026
pulisher
Apr 07, 2026

MacroGenics: Balancing Regulatory Setbacks with Pipeline Promise () - aktiencheck.de

Apr 07, 2026
pulisher
Apr 07, 2026

Dip Buying: Can MacroGenics Inc be the next market leader2026 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 07, 2026

Volatility Watch: What is the next catalyst for MacroGenics IncWeekly Stock Recap & High Return Trade Opportunity Guides - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 04, 2026

Medtronic Outperforms MacroGenics in Financial Comparison - National Today

Apr 04, 2026
pulisher
Apr 02, 2026

MGNX Earnings History & Surprises | EPS & Revenue Results | MACROGENICS INC (NASDAQ:MGNX) - ChartMill

Apr 02, 2026
pulisher
Mar 31, 2026

MacroGenics, Inc. (NASDAQ:MGNX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

MacroGenics, Inc. (NASDAQ:MGNX) Given Consensus Rating of “Hold” by Brokerages - Defense World

Mar 31, 2026
pulisher
Mar 31, 2026

Retail Trends: Can MacroGenics Inc disrupt its industryPortfolio Value Report & Smart Money Movement Alerts - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 29, 2026

Investment Report: Can MacroGenics Inc expand its profit margins2026 Selloffs & Weekly Chart Analysis and Guides - baoquankhu1.vn

Mar 29, 2026
pulisher
Mar 27, 2026

Vanguard reports 0 shares in MacroGenics (NASDAQ: MGNX) - Stock Titan

Mar 27, 2026
pulisher
Mar 26, 2026

Aug Drivers: How does MacroGenics Inc compare to its peersMarket Activity Recap & Short-Term Swing Trade Alerts - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 26, 2026

MacroGenics Secures Financial Runway Ahead of Pivotal Clinical Milestones () - aktiencheck.de

Mar 26, 2026
pulisher
Mar 26, 2026

Treasury Yields: Can MacroGenics Inc disrupt its industry2026 AllTime Highs & Verified High Yield Trade Plans - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 25, 2026

Patterns Watch: What is the next catalyst for MacroGenics IncCEO Change & Fast Exit Strategy with Risk Control - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 25, 2026

VIX Spike: Can MacroGenics Inc be the next market leaderTrade Entry Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn

Mar 25, 2026
pulisher
Mar 24, 2026

MacroGenics (NASDAQ:MGNX) Share Price Crosses Above Fifty Day Moving AverageTime to Sell? - MarketBeat

Mar 24, 2026
pulisher
Mar 21, 2026

Why is MacroGenics stock sinking Tuesday? - MSN

Mar 21, 2026
pulisher
Mar 20, 2026

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus

Mar 20, 2026
pulisher
Mar 18, 2026

Sentiment Review: Will MacroGenics Inc outperform the market in YEAR2026 Big Picture & Fast Gain Stock Tips - baoquankhu1.vn

Mar 18, 2026

Macrogenics Inc (MGNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
大文字化:     |  ボリューム (24 時間):